{"id":"NCT00856284","sponsor":"Takeda","briefTitle":"Efficacy and Safety of Alogliptin Plus Metformin Compared to Glipizide Plus Metformin in Patients With Type 2 Diabetes Mellitus","officialTitle":"A Multicenter, Randomized, Double-Blind, Active-Controlled Study to Evaluate the Durability of the Efficacy and Safety of Alogliptin Compared to Glipizide When Used in Combination With Metformin in Subjects With Type 2 Diabetes","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-03","primaryCompletion":"2012-10","completion":"2012-10","firstPosted":"2009-03-05","resultsPosted":"2013-12-03","lastUpdate":"2013-12-03"},"enrollment":2639,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes Mellitus"],"interventions":[{"type":"DRUG","name":"Alogliptin","otherNames":["SYR-322","Nesina"]},{"type":"DRUG","name":"Metformin","otherNames":["Glucophage"]},{"type":"DRUG","name":"Glipizide","otherNames":["Glucotrol"]}],"arms":[{"label":"Metformin + Alogliptin 12.5 mg","type":"EXPERIMENTAL"},{"label":"Metformin + Alogliptin 25 mg","type":"EXPERIMENTAL"},{"label":"Metformin + Glipizide","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to determine the safety and effectiveness of adding alogliptin, once daily (QD), compared to glipizide with metformin in diabetic patients.","primaryOutcome":{"measure":"Change From Baseline in Glycosylated Hemoglobin (HbA1c) at Week 52","timeFrame":"Baseline and Week 52","effectByArm":[{"arm":"Metformin + Alogliptin 12.5 mg","deltaMin":-0.81,"sd":0.027},{"arm":"Metformin + Alogliptin 25 mg","deltaMin":-0.76,"sd":0.027},{"arm":"Metformin + Glipizide","deltaMin":-0.73,"sd":0.029}],"pValues":[{"comp":"OG001 vs OG002","p":null},{"comp":"OG000 vs OG002","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":15},"locations":{"siteCount":261,"countries":["United States","Argentina","Australia","Austria","Brazil","Canada","Chile","Germany","Guatemala","Hong Kong","Hungary","India","Israel","Italy","Latvia","Lithuania","Malaysia","Mexico","New Zealand","Peru","Philippines","Poland","Puerto Rico","Romania","Russia","Singapore","South Africa","South Korea","Spain","Thailand","Ukraine","United Kingdom"]},"refs":{"pmids":["27787778"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":86,"n":873},"commonTop":["Upper respiratory tract infection","Nasopharyngitis","Diarrhoea","Hypertension","Headache"]}}